Published
ICMR study shows COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well: Indian Council of Medical Research (ICMR). Watch video to know more.
- Category
- Asia
- Tags
- covaxin efficacy, covaxin vaccine, covaxin vaccine bharat biotech
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
00:52
ICMR ने Drone से रच दिया इतिहास, देखते रह गई पूरी दुनिया | Vaccination Drive | Drone | ICMR |
-
02:21
Covid-19 News: Alarmed By Teachers' Deaths, AMU VC Asks ICMR To Study If COVID 'Variant' Responsible
-
22:53
Coronavirus: Facts Vs Myths | Can Covishield-Covaxin Be Mixed? Study Commissioned To Examine It
-
03:14
Most Canadians have antibodies from SARS-CoV-2 infections, new study shows
-
05:42
Covaxin, 3 forms, confusion and multiple rumours: Watch report to know the truth
-
03:17
Covaxin "Effectively Neutralises" Delta Variant, Says Top US Health Institute
-
00:34
Covaxin "Effectively Neutralises" Delta Variant: Top US Health Institute
-
00:51
AstraZeneca, Pfizer vaccines effective against Delta COVID-19 variants: study
-
05:12
Multiple Questions Arise Over Covaxin Approval
-
01:20
Covaxin Found To Be 77.8% Effective Against Covid In Lancet Study
-
03:38
Coronavirus variants spread as 2nd wave eased, analysis shows
-
02:38
Bharat Biotech की Covaxin का तीसरे चरण का ट्रायल सफल | ICMR | Latest News | Hindi News
-
11:59
Covaxin-Covishield Vaccine की कॉकटेल के गजब नतीजे | Mix And Match | ICMR | Precaution Dose | Study
-
01:28
UK approves new double COVID vaccine that targets multiple variants
-
02:14
Covid-19 News | Study On Mixing Covaxin, Covishield Gets Drug Regulator Approval: Sources
-
18:02
Covishield-Covaxin Mix Gives Results, Says Medical Body, Seeks More Study
-
01:38
Multiple sclerosis risk higher for immigrants the longer they stay in Canada, new study finds
-
09:00
New Variants Emerging In Various Countries, Finds Study
-
01:16
Covaxin demonstrates protection against deadly new variants
-
02:42
Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat Biotech
-
04:37
Single-dose vaccine effective against COVID-19 variants, data shows | WNT
-
02:59
Covaxin Phase 3 Data Shows 77.8% Efficacy, Says Lancet
Loading...